company background image
POLYMED logo

Poly Medicure NSEI:POLYMED Stock Report

Last Price

₹1.58k

Market Cap

₹152.0b

7D

5.9%

1Y

68.2%

Updated

27 Mar, 2024

Data

Company Financials +

Poly Medicure Limited

NSEI:POLYMED Stock Report

Market Cap: ₹152.0b

POLYMED Stock Overview

Poly Medicure Limited manufactures and sells medical devices in India and internationally.

POLYMED fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance4/6
Financial Health6/6
Dividends2/6

Rewards

Risk Analysis

No risks detected for POLYMED from our risk checks.

Poly Medicure Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Poly Medicure
Historical stock prices
Current Share Price₹1,584.65
52 Week High₹1,729.00
52 Week Low₹921.10
Beta0.33
1 Month Change1.23%
3 Month Change5.46%
1 Year Change68.25%
3 Year Change92.70%
5 Year Change624.41%
Change since IPO4,313.30%

Recent News & Updates

Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up

Mar 23
Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up

Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today

Feb 15
Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today

Recent updates

Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up

Mar 23
Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up

Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today

Feb 15
Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today

Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Jan 16
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?

Nov 14
Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?

Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward

Oct 24
Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward

Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Sep 22
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00

Sep 08
Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00

Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Aug 12
Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching

Jul 13
Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching

Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return

Jun 16
Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return

Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital

Mar 02
Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital

We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Feb 14
We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal

Oct 16
Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal

We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Sep 28
We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50

Sep 08
Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50

Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Jun 25
Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)

Jun 07
A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)

Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends

May 23
Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends

With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Feb 23
With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital

Feb 04
There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital

Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Jan 12
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Oct 14
With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt

Jul 07
Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt

Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends

Jun 18
Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends

Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals

May 31
Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals

Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195

May 26
Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195

Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return

Mar 01
Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return

I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease

Feb 16
I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease

How Much Is Poly Medicure Limited (NSE:POLYMED) CEO Getting Paid?

Feb 01
How Much Is Poly Medicure Limited (NSE:POLYMED) CEO Getting Paid?

Did Poly Medicure Limited (NSE:POLYMED) Insiders Sell Shares?

Jan 17
Did Poly Medicure Limited (NSE:POLYMED) Insiders Sell Shares?

Poly Medicure Limited's (NSE:POLYMED) Stock Is Going Strong: Is the Market Following Fundamentals?

Dec 09
Poly Medicure Limited's (NSE:POLYMED) Stock Is Going Strong: Is the Market Following Fundamentals?

Announcing: Poly Medicure (NSE:POLYMED) Stock Increased An Energizing 205% In The Last Five Years

Nov 24
Announcing: Poly Medicure (NSE:POLYMED) Stock Increased An Energizing 205% In The Last Five Years

Is Poly Medicure (NSE:POLYMED) Using Too Much Debt?

Nov 09
Is Poly Medicure (NSE:POLYMED) Using Too Much Debt?

Many Would Be Jealous Of Poly Medicure's (NSE:POLYMED) Returns On Capital

Oct 26
Many Would Be Jealous Of Poly Medicure's (NSE:POLYMED) Returns On Capital

Have Insiders Been Selling Poly Medicure Limited (NSE:POLYMED) Shares?

Oct 06
Have Insiders Been Selling Poly Medicure Limited (NSE:POLYMED) Shares?

Should You Be Adding Poly Medicure (NSE:POLYMED) To Your Watchlist Today?

Sep 17
Should You Be Adding Poly Medicure (NSE:POLYMED) To Your Watchlist Today?

Should Poly Medicure Limited (NSE:POLYMED) Be Part Of Your Dividend Portfolio?

Sep 02
Should Poly Medicure Limited (NSE:POLYMED) Be Part Of Your Dividend Portfolio?

Is Poly Medicure Limited's (NSE:POLYMED) Latest Stock Performance A Reflection Of Its Financial Health?

Aug 19
Is Poly Medicure Limited's (NSE:POLYMED) Latest Stock Performance A Reflection Of Its Financial Health?

Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)

Jul 28
Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)

Poly Medicure Limited's (NSE:POLYMED) Share Price Matching Investor Opinion

Jul 14
Poly Medicure Limited's (NSE:POLYMED) Share Price Matching Investor Opinion

Can Poly Medicure (NSE:POLYMED) Prolong Its Impressive Returns?

Jul 09
Can Poly Medicure (NSE:POLYMED) Prolong Its Impressive Returns?

Shareholder Returns

POLYMEDIN Medical EquipmentIN Market
7D5.9%4.6%2.3%
1Y68.2%56.4%48.6%

Return vs Industry: POLYMED exceeded the Indian Medical Equipment industry which returned 56.4% over the past year.

Return vs Market: POLYMED exceeded the Indian Market which returned 48.6% over the past year.

Price Volatility

Is POLYMED's price volatile compared to industry and market?
POLYMED volatility
POLYMED Average Weekly Movement4.6%
Medical Equipment Industry Average Movement6.4%
Market Average Movement6.6%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: POLYMED has not had significant price volatility in the past 3 months.

Volatility Over Time: POLYMED's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19952,339Himanshu Baidhttps://www.polymedicure.com

Poly Medicure Limited manufactures and sells medical devices in India and internationally. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal and tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways.

Poly Medicure Limited Fundamentals Summary

How do Poly Medicure's earnings and revenue compare to its market cap?
POLYMED fundamental statistics
Market cap₹152.04b
Earnings (TTM)₹2.49b
Revenue (TTM)₹13.05b

61.1x

P/E Ratio

11.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
POLYMED income statement (TTM)
Revenue₹13.05b
Cost of Revenue₹4.59b
Gross Profit₹8.45b
Other Expenses₹5.96b
Earnings₹2.49b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)25.92
Gross Margin64.78%
Net Profit Margin19.06%
Debt/Equity Ratio10.1%

How did POLYMED perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

16%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.